Drawing for CELLOSOMES

USPTO serial 85015684

CELLOSOMES

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
FRENCH, CURTIS W
Law office
TMO LAW OFFICE 115 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with CELLOSOMES?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Louis Ventre, Jr.

LOUIS VENTRE, JR. LAW FIRM OF LOUIS VENTRE, JR.2483 OAKTON HILLS DROAKTON, VA 22124-1530UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biological preparations, namely, biochemical preparations for medical or veterinary use, namely, recombinant protein, enzymes, recombinant human enzymes, recombinant human enzymes in bacteria, algae, yeast, and eukaryotic cells, recombinant human drug-metabolizing enzymes; biological preparations, namely, reagents for use in development of monoclonal antibodies for medical use; biological preparations, namely, reagents for use in development of polyclonal antibodies for medical use; biochemical preparations containing enzymes for medical purposes; biochemical preparations containing enzymes for pharmaceutical purposes; biological preparations, namely, bacterial, algae, yeast, and eukaryotic cell membranes for medical use; biological preparations, namely, reagents in kit form for medical useACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 22, 2011MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 22, 2011ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jul 27, 2010CEPECOMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED—
Jul 27, 2010ALIEASSIGNED TO LIE—
Jul 27, 2010GEANNOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 27, 2010GEAPEXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED—
Jul 27, 2010CPEAEXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED—
Jul 26, 2010DOCKASSIGNED TO EXAMINER—
Apr 22, 2010MPMKNOTICE OF PSEUDO MARK MAILED—
Apr 21, 2010NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 20, 2010NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance